GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Wednesday, 17th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.120
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
2023-05-24 $0.758 $0.80 $0.750 $0.790 70 188
2023-05-23 $0.80 $0.80 $0.760 $0.797 82 991
2023-05-22 $0.81 $0.81 $0.760 $0.80 171 217
2023-05-19 $0.80 $0.80 $0.760 $0.789 190 984
2023-05-18 $0.84 $0.84 $0.754 $0.757 251 678
2023-05-17 $0.80 $0.85 $0.750 $0.84 246 802
2023-05-16 $0.790 $0.83 $0.730 $0.790 216 098
2023-05-15 $0.749 $0.82 $0.740 $0.795 294 214
2023-05-12 $0.720 $0.775 $0.720 $0.746 336 296
2023-05-11 $0.778 $0.82 $0.718 $0.80 761 955
2023-05-10 $0.779 $0.88 $0.696 $0.82 1 951 460
2023-05-09 $0.81 $0.81 $0.670 $0.779 4 960 582
2023-05-08 $1.15 $1.31 $0.88 $0.96 100 431 164
2023-05-05 $0.377 $0.406 $0.362 $0.400 131 392
2023-05-04 $0.370 $0.380 $0.355 $0.380 79 064
2023-05-03 $0.375 $0.380 $0.343 $0.379 91 025
2023-05-02 $0.359 $0.384 $0.347 $0.365 197 143
2023-05-01 $0.370 $0.370 $0.340 $0.360 159 572
2023-04-28 $0.331 $0.367 $0.323 $0.350 364 221
2023-04-27 $0.377 $0.549 $0.341 $0.415 4 571 343
2023-04-26 $0.360 $0.371 $0.335 $0.336 95 767
2023-04-25 $0.350 $0.361 $0.330 $0.335 232 193
2023-04-24 $0.330 $0.360 $0.310 $0.338 103 453
2023-04-21 $0.380 $0.405 $0.320 $0.338 318 764
2023-04-20 $0.390 $0.420 $0.360 $0.389 433 759
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT